125 related articles for article (PubMed ID: 33018244)
1. A Weak Supervision-based Framework for Automatic Lung Cancer Classification on Whole Slide Image.
Xu X; Hou R; Zhao W; Teng H; Sun J; Zhao J
Annu Int Conf IEEE Eng Med Biol Soc; 2020 Jul; 2020():1372-1375. PubMed ID: 33018244
[TBL] [Abstract][Full Text] [Related]
2. Lung cancer subtype classification using histopathological images based on weakly supervised multi-instance learning.
Zhao L; Xu X; Hou R; Zhao W; Zhong H; Teng H; Han Y; Fu X; Sun J; Zhao J
Phys Med Biol; 2021 Dec; 66(23):. PubMed ID: 34794136
[No Abstract] [Full Text] [Related]
3. Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning.
Coudray N; Ocampo PS; Sakellaropoulos T; Narula N; Snuderl M; Fenyö D; Moreira AL; Razavian N; Tsirigos A
Nat Med; 2018 Oct; 24(10):1559-1567. PubMed ID: 30224757
[TBL] [Abstract][Full Text] [Related]
4. New vision of HookEfficientNet deep neural network: Intelligent histopathological recognition system of non-small cell lung cancer.
Yuan H; Kido T; Hirata M; Ueno K; Imai Y; Chen K; Ren W; Yang L; Chen K; Qu L; Wu Y
Comput Biol Med; 2024 Jun; 178():108710. PubMed ID: 38843570
[TBL] [Abstract][Full Text] [Related]
5. Classification of subtypes including LCNEC in lung cancer biopsy slides using convolutional neural network from scratch.
Yang JW; Song DH; An HJ; Seo SB
Sci Rep; 2022 Feb; 12(1):1830. PubMed ID: 35115593
[TBL] [Abstract][Full Text] [Related]
6. Identification of expression signatures for non-small-cell lung carcinoma subtype classification.
Su R; Zhang J; Liu X; Wei L
Bioinformatics; 2020 Jan; 36(2):339-346. PubMed ID: 31297509
[TBL] [Abstract][Full Text] [Related]
7. What's the difference between lung adenocarcinoma and lung squamous cell carcinoma? Evidence from a retrospective analysis in a cohort of Chinese patients.
Wang W; Liu H; Li G
Front Endocrinol (Lausanne); 2022; 13():947443. PubMed ID: 36105402
[TBL] [Abstract][Full Text] [Related]
8. The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates.
Meng F; Zhang L; Ren Y; Ma Q
J Cell Physiol; 2019 Jul; 234(7):10918-10925. PubMed ID: 30549039
[TBL] [Abstract][Full Text] [Related]
9. The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC.
Fu L; Wang H; Wei D; Wang B; Zhang C; Zhu T; Ma Z; Li Z; Wu Y; Yu G
PLoS One; 2020; 15(5):e0233283. PubMed ID: 32437446
[TBL] [Abstract][Full Text] [Related]
10. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
Yang Y; Wang M; Liu B
J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
[TBL] [Abstract][Full Text] [Related]
11. LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma.
Liu B; Chen Y; Yang J
Oncotarget; 2017 Apr; 8(15):24275-24291. PubMed ID: 27903974
[TBL] [Abstract][Full Text] [Related]
12. An explainable AI-driven biomarker discovery framework for Non-Small Cell Lung Cancer classification.
Dwivedi K; Rajpal A; Rajpal S; Agarwal M; Kumar V; Kumar N
Comput Biol Med; 2023 Feb; 153():106544. PubMed ID: 36652866
[TBL] [Abstract][Full Text] [Related]
13. Intratumor heterogeneity comparison among different subtypes of non-small-cell lung cancer through multi-region tissue and matched ctDNA sequencing.
Zhang Y; Chang L; Yang Y; Fang W; Guan Y; Wu A; Hong S; Zhou H; Chen G; Chen X; Zhao S; Zheng Q; Pan H; Zhang L; Long H; Yang H; Wang X; Wen Z; Wang J; Yang H; Xia X; Zhao Y; Hou X; Ma Y; Zhou T; Zhang Z; Zhan J; Huang Y; Zhao H; Zhou N; Yi X; Zhang L
Mol Cancer; 2019 Jan; 18(1):7. PubMed ID: 30626401
[TBL] [Abstract][Full Text] [Related]
14. Pathologist-level classification of histologic patterns on resected lung adenocarcinoma slides with deep neural networks.
Wei JW; Tafe LJ; Linnik YA; Vaickus LJ; Tomita N; Hassanpour S
Sci Rep; 2019 Mar; 9(1):3358. PubMed ID: 30833650
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G
Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858
[TBL] [Abstract][Full Text] [Related]
16. Nuclear TAZ activity distinctly associates with subtypes of non-small cell lung cancer.
Wang Y; Han Y; Guo Z; Yang Y; Ren T
Biochem Biophys Res Commun; 2019 Feb; 509(3):828-832. PubMed ID: 30638934
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer Prognosis.
Luo X; Zang X; Yang L; Huang J; Liang F; Rodriguez-Canales J; Wistuba II; Gazdar A; Xie Y; Xiao G
J Thorac Oncol; 2017 Mar; 12(3):501-509. PubMed ID: 27826035
[TBL] [Abstract][Full Text] [Related]
18. Weakly Supervised Framework for Cancer Region Detection of Hepatocellular Carcinoma in Whole-Slide Pathologic Images Based on Multiscale Attention Convolutional Neural Network.
Diao S; Tian Y; Hu W; Hou J; Lambo R; Zhang Z; Xie Y; Nie X; Zhang F; Racoceanu D; Qin W
Am J Pathol; 2022 Mar; 192(3):553-563. PubMed ID: 34896390
[TBL] [Abstract][Full Text] [Related]
19. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
Xu XL; Gong Y; Zhao DP
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913
[TBL] [Abstract][Full Text] [Related]
20. Graph Neural Network for representation learning of lung cancer.
Aftab R; Qiang Y; Zhao J; Urrehman Z; Zhao Z
BMC Cancer; 2023 Oct; 23(1):1037. PubMed ID: 37884929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
